Clinical trial
Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder
NCT00195598 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00195598 |
|---|---|
| Title | Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder |
| Official title | Pilot Study of Venlafaxine Extended Release (XR) in the Treatment of Panic Disorder (PD) in Comparison to Paroxetine. |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Panic Disorders |
| Intervention type | Drug |
| Interventions | VENLAFAXINE, Paroxetine |
| Enrollment | 70 |
| Start date | Jan 1, 2005 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Apr 2, 2010 |
| Countries | Brazil |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: